Recurrent mutation of JAK3 in T-cell prolymphocytic leukemia

Genes Chromosomes and Cancer

Volumn 53, Issue 4, 2014, Pages 309-316

  Bergmann, Anke K ^a   Schneppenheim, Sina ^a   Seifert, Marc ^b   Betts, Matthew J ^c   Haake, Andrea ^a   Lopez, Cristina ^a   Maria Murga Penas, Eva ^a   Vater, Inga ^a   Jayne, Sandrine ^d   Dyer, Martin J S ^d   Schrappe, Martin ^a   Dührsen, Ulrich ^e   Ammerpohl, Ole ^a   Russell, Robert B ^c   Küppers, Ralf ^b   Dürig, Jan ^e   Siebert, Reiner ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMINO ACID SEQUENCE; CHROMOSOMES, HUMAN, PAIR 14; COHORT STUDIES; FEMALE; HUMANS; JANUS KINASE 3; LEUKEMIA, PROLYMPHOCYTIC, T-CELL; MALE; MOLECULAR SEQUENCE DATA; MUTATION;

EID: 84894026125     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22141     Document Type: Article

References (44)

1. Bains T, Heinrich MC, Loriaux MM, Beadling C, Nelson D, Warrick A, Neff TL, Tyner JW, Dunlap J, Corless CL, Fan G. 2012. Newly described activating JAK3 mutations in T-cell acute lymphoblastic leukemia. Leukemia 26:2144-2146.
2. Baird AM, Thomis DC, Berg LJ. 1998. T cell development and activation in Jak3-deficient mice. J Leukoc Biol 63:669-677.
3. Bandaranayake RM, Ungureanu D, Shan Y, Shaw DE, Silvennoinen O, Hubbard SR. 2012. Crystal structures of the JAK2 pseudokinase domain and the pathogenic mutant V617F. Nat Struct Mol Biol 19:754-759.
4. Bellanger D, Jacquemin V, Chopin M, Pierron G, Bernard OA, Ghysdael J, Stern MH. 2013. Recurrent JAK1 and JAK3 somatic mutations in T-cell prolymphocytic leukemia. Leukemia. doi: 10.1038/leu.2013.271.
5. Bouchekioua A, Scourzic L, de Wever O, Zhang Y, Cervera P, Aline-Fardin A, Mercher T, Gaulard P, Nyga R, Jeziorowska D, Douay L, Vainchenker W, Louache F, Gespach C, Solary E, Coppo P. 2013. JAK3 deregulation by activating mutations confers invasive growth advantage in extranodal nasal-type natural killer cell lymphoma. Leukemia doi: 10.1038/leu.2013.157.
6. Brito-Babapulle V, Catovsky D. 1991. Inversions and tandem translocations involving chromosome 14q11 and 14q32 in T-prolymphocytic leukemia and T-cell leukemias in patients with ataxia telangiectasia. Cancer Genet Cytogenet 55:1-9.
7. Brito-Babapulle V, Pomfret M, Matutes E, Catovsky D. 1987. Cytogenetic studies on prolymphocytic leukemia. II. T cell prolymphocytic leukemia. Blood 70:926-931.
8. Brito-Babapulle V, Hamoudi R, Matutes E, Watson S, Kaczmarek P, Maljaie H, Catovsky D. 2000. p53 allele deletion and protein accumulation occurs in the absence of p53 gene mutation in T-prolymphocytic leukaemia and Sezary syndrome. Br J Haematol 110:180-187.
9. Bug S, Durig J, Oyen F, Klein-Hitpass L, Martin-Subero JI, Harder L, Baudis M, Arnold N, Kordes U, Duhrsen U, Schneppenheim R, Siebert R. 2009. Recurrent loss, but lack of mutations, of the SMARCB1 tumor suppressor gene in T-cell prolymphocytic leukemia with TCL1A-TCRAD juxtaposition. Cancer Genet Cytogenet 192:44-47.
10. Catovsky D, Müller-Hermelink HK, Ralfkiaer E. 2008. T-cell prolymphocytic leukaemia. In: Swerdlow SH, Campo E, Lee Harris N, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW, editors. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon: IARC. p 270-271.
11. Cornejo MG, Boggon TJ, Mercher T. 2009a. JAK3: a two-faced player in hematological disorders. Int J Biochem Cell Biol 41:2376-2379.
12. Cornejo MG, Kharas MG, Werneck MB, Le Bras S, Moore SA, Ball B, Beylot-Barry M, Rodig SJ, Aster JC, Lee BH, Cantor H, Merlio JP, Gilliland DG, Mercher T. 2009b. Constitutive JAK3 activation induces lymphoproliferative syndromes in murine bone marrow transplantation models. Blood 113:2746-2754.
13. Dearden CE. 2006. T-cell prolymphocytic leukemia. Med Oncol 23:17-22.
14. Durig J, Bug S, Klein-Hitpass L, Boes T, Jons T, Martin-Subero JI, Harder L, Baudis M, Duhrsen U, Siebert R. 2007. Combined single nucleotide polymorphism-based genomic mapping and global gene expression profiling identifies novel chromosomal imbalances, mechanisms and candidate genes important in the pathogenesis of T-cell prolymphocytic leukemia with inv(14)(q11q32). Leukemia 21:2153-2163.
15. Elliott NE, Cleveland SM, Grann V, Janik J, Waldmann TA, Dave UP. 2011. FERM domain mutations induce gain of function in JAK3 in adult T-cell leukemia/lymphoma. Blood 118:3911-3921.
16. Fisch P, Forster A, Sherrington PD, Dyer MJ, Rabbitts TH. 1993. The chromosomal translocation t(X;14)(q28;q11) in T-cell pro-lymphocytic leukaemia breaks within one gene and activates another. Oncogene 8:3271-3276.
17. Gesk S, Martin-Subero JI, Harder L, Luhmann B, Schlegelberger B, Calasanz MJ, Grote W, Siebert R. 2003. Molecular cytogenetic detection of chromosomal breakpoints in T-cell receptor gene loci. Leukemia 17:738-745.
18. Ghoreschi K, Laurence A, O'Shea JJ. 2009. Janus kinases in immune cell signaling. Immunol Rev 228:273-287.
19. Gritti C, Dastot H, Soulier J, Janin A, Daniel MT, Madani A, Grimber G, Briand P, Sigaux F, Stern MH. 1998. Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. Blood 92:368-373.
20. ISCN. 2013. Edited by Shaffer LG, McGowan-Jordan J, Schmid M. 2013. Basel: S Karger.
21. Koo GC, Tan SY, Tang T, Poon SL, Allen GE, Tan L, Chong SC, Ong WS, Tay K, Tao M, Quek R, Loong S, Yeoh KW, Yap SP, Lee KA, Lim LC, Tan D, Goh C, Cutcutache I, Yu W, Ng CC, Rajasegaran V, Heng HL, Gan A, Ong CK, Rozen S, Tan P, Teh BT, Lim ST. 2012. Janus kinase 3-activating mutations identified in natural killer/T-cell lymphoma. Cancer Discov 2:591-597.
22. Leonard WJ, Shores EW, Love PE. 1995. Role of the common cytokine receptor gamma chain in cytokine signaling and lymphoid development. Immunol Rev 148:97-114.
23. Letunic I, Doerks T, Bork P. 2011. SMART 7: recent updates to the protein domain annotation resource. Nucleic Acids Res 40:D302-305.
24. Li F, Guo HY, Wang M, Geng HL, Bian MR, Cao J, Chen C, Zeng LY, Wang XY, Wu QY. 2013. The effects of R683S (G) genetic mutations on the JAK2 activity, structure and stability. Int J Biol Macromol 60C:186-195.
25. Macchi P, Villa A, Giliani S, Sacco MG, Frattini A, Porta F, Ugazio AG, Johnston JA, Candotti F, O'Shea JJ, Vezzoni P, Notarangelo L D. 1995. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID). Nature 377:65-8.
26. Madani A, Choukroun V, Soulier J, Cacheux V, Claisse JF, Valensi F, Daliphard S, Cazin B, Levy V, Leblond V, Daniel MT, Sigaux F, Stern MH. 1996. Expression of p13MTCP1 is restricted to mature T-cell proliferations with t(X;14) translocations. Blood 87:1923-1927.
27. Malinge S, Ragu C, Della-Valle V, Pisani D, Constantinescu SN, Perez C, Villeval JL, Reinhardt D, Landman-Parker J, Michaux L, Dastugue N, Baruchel A, Vainchenker W, Bourquin JP, Penard-Lacronique V, Bernard OA. 2008. Activating mutations in human acute megakaryoblastic leukemia. Blood 112:4220-4226.
28. Narducci MG, Virgilio L, Isobe M, Stoppacciaro A, Elli R, Fiorilli M, Carbonari M, Antonelli A, Chessa L, Croce CM, Russo G. 1995. TCL1 oncogene activation in preleukemic T cells from a case of ataxia-telangiectasia. Blood 86:2358-2364.
29. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer EL, Eddy SR, Bateman A, Finn RD. 2011. The Pfam protein families database. Nucleic Acids Res 40:D290-301.
30. Russell RB, Barton GJ. 1992. Multiple protein sequence alignment from tertiary structure comparison: assignment of global and residue confidence levels. Proteins 14:309-323.
31. Russell SM, Tayebi N, Nakajima H, Riedy MC, Roberts JL, Aman MJ, Migone TS, Noguchi M, Markert ML, Buckley RH, O'Shea JJ, Leonard WJ. 1995. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800.
32. Sakaguchi H, Okuno Y, Muramatsu H, Yoshida K, Shiraishi Y, Takahashi M, Kon A, Sanada M, Chiba K, Tanaka H, Makishima H, Wang X, Xu Y, Doisaki S, Hama A, Nakanishi K, Takahashi Y, Yoshida N, Maciejewski JP, Miyano S, Ogawa S, Kojima S. 2013. Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia. Nat Genet 45:937-941.
33. Sali A, Blundell TL. 1993. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815.
34. Sato T, Toki T, Kanezaki R, Xu G, Terui K, Kanegane H, Miura M, Adachi S, Migita M, Morinaga S, Nakano T, Endo M, Kojima S, Kiyoi H, Mano H, Ito E. 2008. Functional analysis of JAK3 mutations in transient myeloproliferative disorder and acute megakaryoblastic leukaemia accompanying Down syndrome. Br J Haematol 141:681-688.
35. Schlegelberger B, Metzke S, Harder S, Zühlke-Jenisch R, Zhang Y, Siebert R. 1999. Classical and molecular cytogenetics of tumor cells. In: Wegener R, editor. Diagnostic Cytogenetics. New York, NY: Springer-Verlag, p. 151.
36. Stankovic T, Taylor AM, Yuille MR, Vorechovsky I. 2001. Recurrent ATM mutations in T-PLL on diverse haplotypes: no support for their germline origin. Blood 97:1517-1518.
37. Stern MH, Soulier J, Rosenzwajg M, Nakahara K, Canki-Klain N, Aurias A, Sigaux F, Kirsch IR. 1993. MTCP-1: a novel gene on the human chromosome Xq28 translocated to the T cell receptor alpha/delta locus in mature T cell proliferations. Oncogene 8:2475-2483.
38. Stilgenbauer S, Schaffner C, Litterst A, Liebisch P, Gilad S, Bar-Shira A, James MR, Lichter P, Dohner H. 1997. Biallelic mutations in the ATM gene in T-prolymphocytic leukemia. Nat Med 3:1155-1159.
39. Ventura RA, Martin-Subero JI, Jones M, McParland J, Gesk S, Mason DY, Siebert R. 2006. FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue. J Mol Diagn 8:141-151.
40. Virgilio L, Lazzeri C, Bichi R, Nibu K, Narducci MG, Russo G, Rothstein JL, Croce CM. 1998. Deregulated expression of TCL1 causes T cell leukemia in mice. Proc Natl Acad Sci U S A 95:3885-3889.
41. Vorechovsky I, Luo L, Dyer MJ, Catovsky D, Amlot PL, Yaxley JC, Foroni L, Hammarstrom L, Webster AD, Yuille MA. 1997. Clustering of missense mutations in the ataxia-telangiectasia gene in a sporadic T-cell leukaemia. Nat Genet 17:96-99.
42. Walters DK, Mercher T, Gu TL, O'Hare T, Tyner JW, Loriaux M, Goss VL, Lee KA, Eide CA, Wong MJ, Stoffregen EP, McGreevey L, Nardone J, Moore SA, Crispino J, Boggon TJ, Heinrich MC, Deininger MW, Polakiewicz RD, Gilliland DG, Druker BJ. 2006. Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell 10:65-75.
43. Yamashita Y, Yuan J, Suetake I, Suzuki H, Ishikawa Y, Choi YL, Ueno T, Soda M, Hamada T, Haruta H, Takada S, Miyazaki Y, Kiyoi H, Ito E, Naoe T, Tomonaga M, Toyota M, Tajima S, Iwama A, Mano H. 2010. Array-based genomic resequencing of human leukemia. Oncogene 29:3723-3731.
44. Zhang J, Ding L, Holmfeldt L, Wu G, Heatley SL, Payne-Turner D, Easton J, Chen X, Wang J, Rusch M, Lu C, Chen SC, Wei L, Collins-Underwood JR, Ma J, Roberts KG, Pounds SB, Ulyanov A, Becksfort J, Gupta P, Huether R, Kriwacki RW, Parker M, McGoldrick DJ, Zhao D, Alford D, Espy S, Bobba KC, Song G, Pei D, Cheng C, Roberts S, Barbato MI, Campana D, Coustan-Smith E, Shurtleff SA, Raimondi SC, Kleppe M, Cools J, Shimano KA, Hermiston ML, Doulatov S, Eppert K, Laurenti E, Notta F, Dick JE, Basso G, Hunger SP, Loh ML, Devidas M, Wood B, Winter S, Dunsmore KP, Fulton RS, Fulton LL, Hong X, Harris CC, Dooling DJ, Ochoa K, Johnson KJ, Obenauer JC, Evans WE, Pui CH, Naeve CW, Ley TJ, Mardis ER, Wilson RK, Downing JR, Mullighan CG. 2012. The genetic basis of early T-cell precursor acute lymphoblastic leukaemia. Nature 481:157-163.